OA
SAGE

Outfitter Advisors’s Sage Therapeutics SAGE Stock Holding History

Outfitter Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$1.27M Buy
+8,095
New +$1.27M 0.57% 56

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Outfitter Advisors's SAGE Position: Q2 2018 in Review

Outfitter Advisors opened a new position in Sage Therapeutics (SAGE) in Q2 2018: 8,095 shares worth $1.27M. The stake represents 0.57% of the portfolio and ranks #56 among its holdings.

269 funds tracked by Wall St. Rank hold SAGE as of Q2 2018.

  • Outfitter Advisors held 8,095 shares of Sage Therapeutics worth $1.27M as of Q2 2018.
  • Sage Therapeutics was a new Outfitter Advisors position in Q2 2018.
  • Sage Therapeutics made up 0.57% of Outfitter Advisors's portfolio in Q2 2018, its #56 holding.
  • 269 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2018.

Based on Outfitter Advisors's 13F filing for Q2 2018, filed 23 Jul 2018.